judge wopner
TRIBE Member
Study Analysis Shows That Eltrombopag Significantly Improves Platelet Count and Response Rates in Idiopathic Thrombocytopenic Purpura (ITP)
Monday June 19, 8:00 am ET
Phase II trial data show that treatment with eltrombopag significantly improves platelet count with up to 81% of patients achieving the primary clinical endpoint of this study.
-------------------------------
its about time!!
Monday June 19, 8:00 am ET
Phase II trial data show that treatment with eltrombopag significantly improves platelet count with up to 81% of patients achieving the primary clinical endpoint of this study.
-------------------------------
its about time!!